Delivery Order SPE2DB22D9304-SPE2DB25FSSH3

Award Date 10/31/24
Potential Completion Date 11/22/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $74,275.20 firm fixed-price contract is for the delivery of Xolair 150 mg/mL syringes, a specialized biologic medication, to support the recurring medical supply needs of military health facilities. The award is issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,802.75 firm fixed-price contract is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product, with a period of performance through December 19, 2023. The order was placed against DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,321.10 award is for the delivery of Xolair 75 mg/0.5 ml syringes to support the recurring medical supply needs of military health facilities. The award was made under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,934.25 and is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of Xolair 75 mg/0.5 ml syringe 0.5 ml to support the recurring medical supply needs of military health facilities worldwide. This award is issued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,605.50 firm fixed-price contract is for the delivery of Xolair 150 mg/ml syringes, a specialized medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which covers a wide range of pharmaceutical products including branded and generic prescription drugs,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, valued at $7,737.00, is for the supply of Xolair 150 mg/mL syringes to support the medical needs of military healthcare facilities. The award is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,934.25, is a firm fixed-price order for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes, valued at $1,547.40, with a performance period through May 6, 2024. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue firm fixed-price...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the SPE2DB program, a $499,999,999 Indefinite Delivery Contract (IDC) that allows the DLA to issue firm fixed-price orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB25FSSH3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $2,321.10, is for the delivery of Xolair 75 mg/0.5 ml syringes.

The contract is a firm fixed-price delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides critical pharmaceutical products and services to the Department of Defense healthcare system.

Generated 1/30/25, 9:30 AM